Fig. 1From: Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomesResults of bone marrow MSC and SC laboratory assessments. A S-100 immunocytological staining negative control. B S-100 immunocytological staining test. C The cell surface marker (CD73, CD105, CD45, and CD34) analysis through flow cytometryBack to article page